{"id":2969,"date":"2026-07-23T07:26:02","date_gmt":"2026-07-23T07:26:02","guid":{"rendered":"https:\/\/whmnews.ir\/En\/?p=2969"},"modified":"2026-07-23T07:26:02","modified_gmt":"2026-07-23T07:26:02","slug":"gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro","status":"publish","type":"post","link":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/","title":{"rendered":"GSK enters lung cancer drug market with early FDA nod for Jideytro"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>GSK enters lung cancer drug market with early FDA nod for Jideytro<\/strong><\/p>\n<p style=\"text-align: justify;\">GSK\u00a0<a href=\"https:\/\/www.reuters.com\/markets\/companies\/GSK.L\">(GSK.L), opens new tab<\/a>\u00a0said on Wednesday the U.S. FDA approved its drug \u200bto treat a form of lung cancer, nearly two months after \u200cthe British drugmaker acquired the treatment as part of a historic $10.6 billion deal.<\/p>\n<p style=\"text-align: justify;\">The approval, which marks GSK&#8217;s entry into a lucrative market for lung cancer treatment, comes earlier than the \u200bFDA&#8217;s target action date of September 18.<\/p>\n<p style=\"text-align: justify;\">It accelerates GSK&#8217;s rebuild of a \u200bcancer drug business under new CEO Luke Miels, who took over \u2060in January and is tasked with leading the company to its ambitious target \u200bof over \u00a340 billion in annual sales by 2031.<\/p>\n<p style=\"text-align: justify;\">The drug Jideytro was approved for \u200bpreviously treated patients with ROS1-positive non-small cell lung cancer, a rare subtype driven by an altered ROS1 protein that fuels cancer growth and spread.<\/p>\n<p style=\"text-align: justify;\">The drug will compete with Bristol Myers Squibb&#8217;s\u00a0<a href=\"https:\/\/www.reuters.com\/markets\/companies\/BMY.N\">(BMY.N), opens new tab<\/a>\u00a0\u200bAugtyro, as well as older treatments Roche&#8217;s\u00a0<a href=\"https:\/\/www.reuters.com\/markets\/companies\/ROPC.S\">(ROPC.S), opens new tab<\/a>\u00a0Rozlytrek and Pfizer&#8217;s\u00a0<a href=\"https:\/\/www.reuters.com\/markets\/companies\/PFE.N\">(PFE.N), opens new tab<\/a>\u00a0Xalkori.<\/p>\n<p style=\"text-align: justify;\">Lung cancer is \u200bone of the biggest segments of the global oncology market, generating billions of dollars in annual \u200cdrug \u2060sales.<\/p>\n<p style=\"text-align: justify;\">The approval was based on data from an early- to mid-stage trial involving patients previously treated with ROS1-targeted medicines. The trial was conducted by U.S. biotech Nuvalent, which GSK\u00a0<a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/uks-gsk-buy-us-based-cancer-drugmaker-nuvalent-106-billion-2026-06-09\/\">acquired last month<\/a>.<\/p>\n<p style=\"text-align: justify;\">In the trial, 44% of 117 patients had their tumors \u200bshrink or disappear, and \u200bamong those who \u2060responded to the treatment, 82% were still responding at six months and 69% at 12 months.<\/p>\n<p style=\"text-align: justify;\">The FDA is expected to \u200bmake a decision on Nuvalent&#8217;s second lung cancer drug, neladalkib, \u200bby November.<\/p>\n<p style=\"text-align: justify;\">GSK \u2060is also accelerating the development of a third drug, ris-rez,\u00a0<a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/gsks-targeted-cancer-therapy-shows-positive-results-late-stage-study-2026-07-10\/\">which met its main goal<\/a>\u00a0of improving survival in a late-stage trial of patients in China.<\/p>\n<p style=\"text-align: justify;\">A GSK spokesperson told \u2060Reuters, &#8220;We \u200bare working to ensure patients have access to \u200bJideytro as soon as possible with medicine available in pharmacies in the coming weeks.&#8221;<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>GSK enters lung cancer drug market with early FDA nod for Jideytro GSK\u00a0(GSK.L), opens new tab\u00a0said on Wednesday the U.S. FDA approved its drug \u200bto treat a form of lung cancer, nearly two months after \u200cthe British drugmaker acquired the treatment as part of a historic $10.6 billion deal. The approval, which marks GSK&#8217;s entry [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2970,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[979],"class_list":["post-2969","post","type-post","status-publish","format-standard","has-post-thumbnail","category-food-and-drug-organization","tag-gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.1 (Yoast SEO v24.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GSK enters lung cancer drug market with early FDA nod for Jideytro - whmnews<\/title>\n<meta name=\"description\" content=\"GSK enters lung cancer drug market with early FDA nod for Jideytro\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK enters lung cancer drug market with early FDA nod for Jideytro\" \/>\n<meta property=\"og:description\" content=\"GSK enters lung cancer drug market with early FDA nod for Jideytro\" \/>\n<meta property=\"og:url\" content=\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\" \/>\n<meta property=\"og:site_name\" content=\"whmnews\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T07:26:02+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"975\" \/>\n\t<meta property=\"og:image:height\" content=\"549\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Roza News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Roza News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\"},\"author\":{\"name\":\"Roza News\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/77fef232f03e0a43eb2c2ecc12e4de2e\"},\"headline\":\"GSK enters lung cancer drug market with early FDA nod for Jideytro\",\"datePublished\":\"2026-07-23T07:26:02+00:00\",\"dateModified\":\"2026-07-23T07:26:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\"},\"wordCount\":352,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg\",\"keywords\":[\"GSK enters lung cancer drug market with early FDA nod for Jideytro\"],\"articleSection\":[\"Food and Drug Organization\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\",\"url\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\",\"name\":\"GSK enters lung cancer drug market with early FDA nod for Jideytro - whmnews\",\"isPartOf\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg\",\"datePublished\":\"2026-07-23T07:26:02+00:00\",\"dateModified\":\"2026-07-23T07:26:02+00:00\",\"description\":\"GSK enters lung cancer drug market with early FDA nod for Jideytro\",\"breadcrumb\":{\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage\",\"url\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg\",\"contentUrl\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg\",\"width\":975,\"height\":549},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/whmnews.ir\/En\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK enters lung cancer drug market with early FDA nod for Jideytro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/whmnews.ir\/En\/#website\",\"url\":\"https:\/\/whmnews.ir\/En\/\",\"name\":\"whmnews\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/whmnews.ir\/En\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/whmnews.ir\/En\/#organization\",\"name\":\"World Health and Medicine News\",\"url\":\"https:\/\/whmnews.ir\/En\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png\",\"contentUrl\":\"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png\",\"width\":387,\"height\":181,\"caption\":\"World Health and Medicine News\"},\"image\":{\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/77fef232f03e0a43eb2c2ecc12e4de2e\",\"name\":\"Roza News\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/whmnews.ir\/En\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b2b23fed0bb80c5fe651202e69a75e2b079e147751aa945606f536a5bd8e64ef?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b2b23fed0bb80c5fe651202e69a75e2b079e147751aa945606f536a5bd8e64ef?s=96&d=mm&r=g\",\"caption\":\"Roza News\"},\"sameAs\":[\"http:\/\/whmnews\"],\"url\":\"https:\/\/whmnews.ir\/En\/index.php\/author\/journalist\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GSK enters lung cancer drug market with early FDA nod for Jideytro - whmnews","description":"GSK enters lung cancer drug market with early FDA nod for Jideytro","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/","og_locale":"en_US","og_type":"article","og_title":"GSK enters lung cancer drug market with early FDA nod for Jideytro","og_description":"GSK enters lung cancer drug market with early FDA nod for Jideytro","og_url":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/","og_site_name":"whmnews","article_published_time":"2026-07-23T07:26:02+00:00","og_image":[{"width":975,"height":549,"url":"http:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg","type":"image\/jpeg"}],"author":"Roza News","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Roza News","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#article","isPartOf":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/"},"author":{"name":"Roza News","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/77fef232f03e0a43eb2c2ecc12e4de2e"},"headline":"GSK enters lung cancer drug market with early FDA nod for Jideytro","datePublished":"2026-07-23T07:26:02+00:00","dateModified":"2026-07-23T07:26:02+00:00","mainEntityOfPage":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/"},"wordCount":352,"commentCount":0,"publisher":{"@id":"https:\/\/whmnews.ir\/En\/#organization"},"image":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage"},"thumbnailUrl":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg","keywords":["GSK enters lung cancer drug market with early FDA nod for Jideytro"],"articleSection":["Food and Drug Organization"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/","url":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/","name":"GSK enters lung cancer drug market with early FDA nod for Jideytro - whmnews","isPartOf":{"@id":"https:\/\/whmnews.ir\/En\/#website"},"primaryImageOfPage":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage"},"image":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage"},"thumbnailUrl":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg","datePublished":"2026-07-23T07:26:02+00:00","dateModified":"2026-07-23T07:26:02+00:00","description":"GSK enters lung cancer drug market with early FDA nod for Jideytro","breadcrumb":{"@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#primaryimage","url":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg","contentUrl":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2026\/07\/GSK-enters-lung-cancer-drug-market-with-early-FDA-nod-for-Jideytro.jpg","width":975,"height":549},{"@type":"BreadcrumbList","@id":"https:\/\/whmnews.ir\/En\/index.php\/2026\/07\/23\/gsk-enters-lung-cancer-drug-market-with-early-fda-nod-for-jideytro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/whmnews.ir\/En\/"},{"@type":"ListItem","position":2,"name":"GSK enters lung cancer drug market with early FDA nod for Jideytro"}]},{"@type":"WebSite","@id":"https:\/\/whmnews.ir\/En\/#website","url":"https:\/\/whmnews.ir\/En\/","name":"whmnews","description":"","publisher":{"@id":"https:\/\/whmnews.ir\/En\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/whmnews.ir\/En\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/whmnews.ir\/En\/#organization","name":"World Health and Medicine News","url":"https:\/\/whmnews.ir\/En\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/","url":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png","contentUrl":"https:\/\/whmnews.ir\/En\/wp-content\/uploads\/2024\/12\/logo-whmnews-1.png","width":387,"height":181,"caption":"World Health and Medicine News"},"image":{"@id":"https:\/\/whmnews.ir\/En\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/77fef232f03e0a43eb2c2ecc12e4de2e","name":"Roza News","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/whmnews.ir\/En\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b2b23fed0bb80c5fe651202e69a75e2b079e147751aa945606f536a5bd8e64ef?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b2b23fed0bb80c5fe651202e69a75e2b079e147751aa945606f536a5bd8e64ef?s=96&d=mm&r=g","caption":"Roza News"},"sameAs":["http:\/\/whmnews"],"url":"https:\/\/whmnews.ir\/En\/index.php\/author\/journalist\/"}]}},"_links":{"self":[{"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/2969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/comments?post=2969"}],"version-history":[{"count":1,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/2969\/revisions"}],"predecessor-version":[{"id":2971,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/posts\/2969\/revisions\/2971"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/media\/2970"}],"wp:attachment":[{"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/media?parent=2969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/categories?post=2969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/whmnews.ir\/En\/index.php\/wp-json\/wp\/v2\/tags?post=2969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}